The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

As the National Science Foundation faces an existential threat from DOGE and the Trump administration, Congress has yet ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Technology has always been at the heart of human progress. From the invention of the wheel to the rise of the internet, it ...

Alarm bells are again ringing in Brazil, The country might have impressive foreign trade figures and surpluses, but Brazil ...

Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

AbTherx and Single Cell Technology incorporate ActivMAb® Technology into Atlas™ Mouse and AbTheneum™ antibody discovery platforms MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, Inc., a ...

Me’s bankruptcy could put millions of Americans’ genomic profiles at risk of being sold to the Chinese Communist Party, who ...

Preparations for the first analytica USA, the international trade fair for laboratory technology, analysis, biotechnology and ...

The model of assistive technology introduced by Iran at the Global Cooperation on Assistive Technology (GATE) summit 2025 has ...

Money flows out of Harvard into biotechs, housing projects, and retail storefronts. The school powers hospitals, tourism, and ...

We have a responsibility to ensure that our discoveries are used in the public interest. That isn’t always easy.